FDA Approves Itovebi
On October 10, 2024, the FDA approved inavolisib (ItovebiTM, Genentech, Inc.) with palbociclib (Ibrance®) and fulvestrant (Faslodex®) and a companion diagnostic...
Read MoreHow Does a Drug Get FDA Approved After Clinical Trials?
If you participated in a clinical trial for an experimental drug or are considering doing so, you may be interested in learning how a drug goes from being...
Read MoreEuropean Society for Medical Oncology (ESMO) 2024
ESMO recently held its 2024 conference from September 13-17, 2024 in Barcelona, Spain. Click the links below to learn about MBC-related results from this meeting....
Read MoreDifferent Types of Imaging Scans: Bone Scans
In June 2024, we provided an overview of the different types of imaging scans you may receive if you have MBC. Then we began a deeper dive into each scan,...
Read MoreNewly Diagnosed with MBC: Advice from People with MBC
If you are newly diagnosed with MBC, you probably have many questions and concerns. People living with MBC have shared practical information and advice about what...
Read MoreThe Latest in Treatments for MBC With Brain Metastases
Due to ongoing research, newly approved therapies, and changes to clinical trial design that allow more people with MBC who have brain metastases to enroll, there...
Read MoreHighlighting MBC Awareness Day 2024
Every year during Breast Cancer Awareness Month in October, one day, October 13, is set aside as MBC Awareness Day. Read below to learn about MBC Awareness Day. ...
Read MoreDecoding the Different Types of MBC Treatment
Treatments for MBC fall into different categories. You may hear terms like targeted therapy, chemotherapy, hormone therapy, and immunotherapy. These are all...
Read MoreDifferent Types of Imaging Scans: PET/CT Scans
In June 2024, we provided an overview of the different types of imaging scans you may receive if you have MBC. Then we began a deeper dive into each scan,...
Read MoreSEARCH OUR SITE
for past articles or specific information.